腹腔镜脾切除联合贲门周围血管离断术后门静脉系统血栓的早期预防与危险因素分析
本研究纳入2015年1月至2021年1月行腹腔镜脾切除联合贲门周围血管离断术的131例门脉高压合并脾功能亢进患者,分为华法林组(n=68)与阿司匹林组(n=63),并分析PVST组(n=48)与非PVST组(n=83)的血栓危险因素。结果显示华法林组PVST发生20例(29.4%),阿司匹林组28例(44.4%),华法林组术后第一年PVST发生概率低于阿司匹林组(F=13.43,P=0.006);糖尿病、门静脉直径、脾静脉直径及门静脉血流速度为PVST的危险因素。
要点
- 华法林组PVST发生率29.4%,低于阿司匹林组44.4%
- 糖尿病、门静脉直径、脾静脉直径及门静脉流速为PVST危险因素
- 华法林预防性抗凝较阿司匹林降低术后第一年PVST发生概率
核心结论
- 门静脉直径、脾静脉直径、门静脉血流速度及糖尿病是LSD术后PVST的危险因素。
- 与阿司匹林相比,预防性使用华法林抗凝可显著降低门脉高压患者LSD术后PVST发生概率。
研究设计与样本
- 回顾性分析2015年1月至2021年1月行LSD的131例患者,分为华法林组(n=68)与阿司匹林组(n=63)。
- 同时按是否发生PVST分为PVST组(n=48)与非PVST组(n=83)进行危险因素分析。
主要发现
- 华法林组20例(29.4%)发生PVST,阿司匹林组28例(44.4%)发生PVST。
- 华法林组术后第一年PVST发生概率低于阿司匹林组(F=13.43,P=0.006)。
- PVST组与非PVST组在糖尿病、门静脉直径、脾静脉直径及门静脉血流速度方面差异有统计学意义(P<0.05)。
- 多因素logistic回归显示糖尿病、门静脉直径、脾静脉直径及门静脉血流速度为PVST危险因素。
关键数值与推荐
- 华法林组PVST发生率29.4%(20/68),阿司匹林组44.4%(28/63)。
- 术后第一年PVST发生概率华法林组低于阿司匹林组(F=13.43,P=0.006)。
- 糖尿病、门静脉直径、脾静脉直径及门静脉血流速度在PVST组与非PVST组间差异有统计学意义(P<0.05)。
临床怎么用
- 对门脉高压合并脾功能亢进行LSD患者,应评估糖尿病、门静脉及脾静脉直径、门静脉血流速度等PVST危险因素。
- 预防性抗凝可优先考虑华法林而非阿司匹林,以降低术后第一年PVST发生概率。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Portal vein system thrombosis (PVST) is a common postoperative complication brought by laparoscopic splenectomy and pericardial disconnection (LSD) among patients who suffered from portal hypertension and hypersplenism. This research lies mainly in probing into the risk factors of PVST and evaluating the effects of warfarin on PVST prevention. MATERIALS AND METHODS: We took 131 individuals who have carried out LSD from January 2015 to January 2021. Patients were divided into warfarin group (n = 68) and aspirin group (n = 63). Meanwhile, thrombosis factors were analyzed in PVST arm (n = 48) and non-PVST arm (n = 83). RESULTS: We analyzed the early postoperative anticoagulation effect, 20 patients (29.4%) in the warfarin group developed PVST, and 28 patients (44.4%) in the aspirin group. The chance to PVST during the first year after operation was lower in the warfarin group than in the aspirin group (F = 13.43, P = 0.006). Risk factors for PVST were analyzed, and diabetes, the diameter of the portal vein and splenic vein, and the velocity of portal blood flow were statistically significant between the PVST arm and non-PVST arm (P < < 0.05). Multiple logistic regression analyses have shown that diabetes, portal vein diameter, splenic vein diameter, and the velocity of portal blood flow were the risk factors of PVST. CONCLUSIONS: The portal vein diameter, splenic vein diameter, portal vein flow velocity, and diabetes are risk factors for the PVST after LSD. The prophylactic use of warfarin anticoagulation markedly decreases the probability of occurrence of the PVST in patients with portal hypertension after LSD compared to aspirin.
引用
- Li Y, Fu X, Li Y, et al. Early prevention and risk factors analysis of portal vein system thrombosis after laparoscopic splenectomy and pericardial devascularization. Surg Endosc. 2022. PMID: 35764840. doi:10.1007/s00464-022-09340-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。